Aktiesnakken — Juni 2013
-
"Genmab har tildelt warrants til en ledende medarbejder.
Samlet er der udstedt 3000 warrants til medarbejderen, der er ansat i et datterselskab.
Udnyttelseskursen er sat til 199 kr., og den gennemsnitlige værdi er udregnet til 85,39 kr.
Tildelingen kan udnyttes over fire omgange efter henholdsvis et, to, tre og fire år tildelingen. De udløber efter syv år."
/ritzau/FINANS
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind